Neue Suche | Kongressdetail
Druckansicht
 
 

2nd Annual RNAi-Based Therapeutics Summit - June 2021 - Digital Event

Evvnt Promotion / evvnt
-
15.06.2021 - 17.06.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Kongressthemen
As investments and collaborations hit a record high, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases, exciting efforts have now turned to a wide range of other diseases, from CNS, oncology, metabolism and more. Despite the growing momentum, much needs to be addressed in terms of targeted delivery, safety, and efficiency to fully unleash the therapeutic value of RNAi drugs.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Greg Hinkle Vice President, Research Informatics Alnylam Pharmaceuticals, Ekkehard Leberer Senior Director, R&D Alliance Management Sanofi, Julia Alterman Senior Scientist Khvorova Lab University of Massachusetts Medical School and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/733422-0?pid=4832
Herr Customer Service
 
Kategorien
Allgemeinmedizin, Public Health
Sprache
Englisch
Kongressgebühr
Conference Only: USD 1999.00, Conference + 1 Workshop: USD 2348.00, Conference + 2 Workshops: USD 2697.00
Teilnehmer erwartet
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Österreichische Gesellschaft für Public HealthCenter of ExcellenceEuropean Public Health Association (EUPHA)OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation European Health Forum GasteinHelix - Forschung & Beratung WienHilfswerk AustriaCharité International Academy